SCHEMBL3923591

SCHEMBL3923591

CCCCCCCCCCC1c2ccccc2C2(CCCNC2)OC1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3926906 1.00 — —
SCHEMBL3917884 0.82 SIGMAR1 (0.42) —
SCHEMBL3916745 0.77 SIGMAR1 (0.41) —
SCHEMBL4190189 0.73 — —
SCHEMBL13744122 0.68 SIGMAR1 (0.53) —
SCHEMBL3919858 0.68 SIGMAR1 (0.71) —
SCHEMBL11781822 0.67 OPRD1 (0.44) —
SCHEMBL11742682 0.63 HTR2A (0.38) —
SCHEMBL8485367 0.60 ADRA2A (0.60) —
SCHEMBL8494118 0.60 SIGMAR1 (0.84) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038287-A1 SPIRO[BENZOPYRAN]OR SPIRO[BENZOFURAN]DERIVATIVES WHICH INHIBIT THE SIGMA RECEPTOR Laboratorios Del. Dr. Esteve, S.A. (ES) 2009-03-25 — — EP disclosed
WO-2007121976-A1 SPIRO[BENZOPYRAN] OR SPIRO[BENZOFURAN] DERIVATIVES WHICH INHIBIT THE SIGMA RECEPTOR LABORATORIOS DEL. DR. ESTEVE, S.A. (ES) 2007-11-01 — — WO disclosed
Send feedback